Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SF2000SD Safety in Healthy Male Volunteers
NCT02941159Phase 1Unknown
- Sponsor
- Tropical Diseases Research Centre
- Start
- Sep 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of SF2000SD in human immunodeficiency virus infection (HIV), sponsored by Tropical Diseases Research Centre. Primary endpoint: Clinical Adverse Events at 56 days. Status: unknown.
02
Drugs
SF2000SD
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02941159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941159.